A Phase 4 Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients with Polyneuropathy of Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with a V122I or T60A Mutation

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Observational

Locations

Outpatient CTRC
University of Colorado Hospital

Study ID

Protocol Number: 19-3061

More information available at ClinicalTrials.gov: NCT04201418

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers